SALG would like to draw attention to the recent publications from the Association of Anaesthetists and MHRA regarding perioperative care of patients currently taking GLP-1 agonist medications (e.g. Ozempic, Wegovy etc.).

The Association of Anaesthetists has produced an infographic that usefully summarises s the main points in the full consensus statement published in Anaesthesia.¹

The MHRA has also produced a Drug Safety Update on this topic,² that references the above clinical guidance.

1. El-Boghdadly, K et al. Elective perioperative management of adults taking glucagon-like peptide-1 receptor agonists, glucose-dependent insulinotropic peptide agonists and sodium-glucose cotransporter-2 inhibitors: a multidisciplinary consensus statement. Anaes 2025, Apr; 80(4):412-424.
2. Medicines and Healthcare Products Regulatory Agency. Drug Safety Update: GLP-1 and dual GIP/GLP-1 receptor agonists: potential risk of pulmonary aspiration during general anaesthesia or deep sedation. January, 2025 [Accessed 10 April, 2025]